Share this postEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionmember.snowballresearch.comCopy linkFacebookEmailNoteOtherEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionApr 27, 2024∙ PaidShare this postEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionmember.snowballresearch.comCopy linkFacebookEmailNoteOtherShareEpizyme (EPZM) - Aug 2021616KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext